![Stephen Ruddy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Ruddy
Keine laufenden Positionen mehr
Profil
Stephen B. Ruddy worked as Senior Director-Technology Development at Shire ViroPharma, Inc. from 2012 to 2014.
He then worked as Vice President-Pharmaceutical Development at Tesaro, Inc. from 2015 to 2018.
Ruddy's former job titles culminated in his role as Chief Technical Officer & Senior Vice President at Deciphera Pharmaceuticals, Inc. Ruddy earned an undergraduate and doctorate degree from The University of North Carolina at Chapel Hill.
Ehemalige bekannte Positionen von Stephen Ruddy
| Unternehmen | Position | Ende |
|---|---|---|
| TESARO INC | Corporate Officer/Principal | 01.05.2018 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | 01.12.2014 |
| DECIPHERA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Stephen Ruddy
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
44
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
